CDNA News & Events

CareDx announced that Keith Kennedy, the company's COO, will also assume the responsibilities of CFO and oversee the company's finance organization effective February 26. Kennedy has served as COO since September 2024. Nathan Smith announced on the company's quarterly earnings call that he will be stepping down from his role as CFO.

Sees FY26 adjusted EBITDA $30M-$45M.

Reports Q4 revenue $108M, consensus $102.74M. "We delivered a strong finish to 2025, reflecting disciplined execution across the business and continued momentum in our core testing services, patient and digital solutions, and lab products," said John W. Hanna, President and CEO of CareDx. "As we enter 2026, we believe we are well positioned to build on this momentum and continue delivering meaningful value for transplant patients, clinicians, and shareholders."